| Year |
Citation |
Score |
| 2024 |
Mortelecque J, Zejneli O, Bégard S, Simões MC, ElHajjar L, Nguyen M, Cantrelle FX, Hanoulle X, Rain JC, Colin M, Gomes CM, Buée L, Landrieu I, Danis C, Dupré E. A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the Tau intrinsically disordered protein. The Journal of Biological Chemistry. 107163. PMID 38484799 DOI: 10.1016/j.jbc.2024.107163 |
0.532 |
|
| 2024 |
Lefebvre C, Vreulx AC, Dumortier C, Bégard S, Gelle C, Siedlecki-Wullich D, Colin M, Kilinc D, Halliez S. Integration of Microfluidic Devices with Microelectrode Arrays to Functionally Assay Amyloid-β-Induced Synaptotoxicity. Acs Biomaterials Science & Engineering. PMID 38385618 DOI: 10.1021/acsbiomaterials.3c00997 |
0.335 |
|
| 2023 |
Ghazal M, Susloparova A, Lefebvre C, Daher Mansour M, Ghodhbane N, Melot A, Scholaert C, Guérin D, Janel S, Barois N, Colin M, Buée L, Yger P, Halliez S, Coffinier Y, et al. Electropolymerization processing of side-chain engineered EDOT for high performance microelectrode arrays. Biosensors & Bioelectronics. 237: 115538. PMID 37506488 DOI: 10.1016/j.bios.2023.115538 |
0.402 |
|
| 2023 |
Perbet R, Zufferey V, Leroux E, Parietti E, Espourteille J, Culebras L, Perriot S, Du Pasquier R, Bégard S, Deramecourt V, Déglon N, Toni N, Buée L, Colin M, Richetin K. Tau Transfer via Extracellular Vesicles Disturbs the Astrocytic Mitochondrial System. Cells. 12. PMID 37048058 DOI: 10.3390/cells12070985 |
0.587 |
|
| 2023 |
Ghazal M, Scholaert C, Dumortier C, Lefebvre C, Barois N, Janel S, Tarhan MC, Colin M, Buée L, Halliez S, Pecqueur S, Cofinier Y, Alibart F, Yger P. Precision of neuronal localization in 2D cell cultures by using high-performance electropolymerized microelectrode arrays correlated with optical imaging. Biomedical Physics & Engineering Express. PMID 36745905 DOI: 10.1088/2057-1976/acb93e |
0.451 |
|
| 2022 |
Denechaud M, Geurs S, Comptdaer T, Bégard S, Garcia-Núñez A, Pechereau LA, Bouillet T, Vermeiren Y, De Deyn PP, Perbet R, Deramecourt V, Maurage CA, Vanderhaegen M, Vanuytven S, Lefebvre B, ... ... Colin M, et al. Tau promotes oxidative stress-associated cycling neurons in S phase as a pro-survival mechanism: possible implication for Alzheimer's disease. Progress in Neurobiology. 102386. PMID 36481386 DOI: 10.1016/j.pneurobio.2022.102386 |
0.603 |
|
| 2022 |
Bouillet T, Ciba M, Lourenço Alves C, Rodrigues FA, Thielemann C, Colin M, Buée L, Halliez S. Revisiting the involvement of tau in complex neural network remodeling: analysis of the extracellular neuronal activity in organotypic brain slice co-cultures. Journal of Neural Engineering. PMID 36374001 DOI: 10.1088/1741-2552/aca261 |
0.599 |
|
| 2022 |
Arandel L, Matloka M, Klein AF, Rau F, Sureau A, Ney M, Cordier A, Kondili M, Polay-Espinoza M, Naouar N, Ferry A, Lemaitre M, Begard S, Colin M, Lamarre C, et al. Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats. Nature Biomedical Engineering. 6: 207-220. PMID 35145256 DOI: 10.1038/s41551-021-00838-2 |
0.413 |
|
| 2022 |
Danis C, Dupré E, Zejneli O, Caillierez R, Arrial A, Bégard S, Mortelecque J, Eddarkaoui S, Loyens A, Cantrelle FX, Hanoulle X, Rain JC, Colin M, Buée L, Landrieu I. Inhibition of Tau seeding by targeting Tau nucleation core within neurons with a single domain antibody fragment. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35007758 DOI: 10.1016/j.ymthe.2022.01.009 |
0.652 |
|
| 2021 |
Leroux É, Perbet R, Buée L, Colin M. [Extracellular vesicles in the central nervous system]. Medecine Sciences : M/S. 37: 1133-1138. PMID 34928217 DOI: 10.1051/medsci/2021205 |
0.488 |
|
| 2021 |
Leroux E, Perbet R, Caillierez R, Richetin K, Lieger S, Espourteille J, Bouillet T, Bégard S, Danis C, Loyens A, Toni N, Déglon N, Deramecourt V, Schraen-Maschke S, Buée L, ... Colin M, et al. Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 34563677 DOI: 10.1016/j.ymthe.2021.09.020 |
0.637 |
|
| 2020 |
Richetin K, Steullet P, Pachoud M, Perbet R, Parietti E, Maheswaran M, Eddarkaoui S, Bégard S, Pythoud C, Rey M, Caillierez R, Q Do K, Halliez S, Bezzi P, Buée L, ... ... Colin M, et al. Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer's disease. Nature Neuroscience. PMID 33169029 DOI: 10.1038/s41593-020-00728-x |
0.592 |
|
| 2020 |
Susloparova A, Halliez S, Begard S, Colin M, Buée L, Pecqueur S, Alibart F, Thomy V, Arscott S, Pallecchi E, Coffinier Y. Low impedance and highly transparent microelectrode arrays (MEA) for in vitro neuron electrical activity probing Sensors and Actuators B-Chemical. 128895. DOI: 10.1016/J.Snb.2020.128895 |
0.458 |
|
| 2019 |
Colin M, Dujardin S, Schraen-Maschke S, Meno-Tetang G, Duyckaerts C, Courade JP, Buée L. From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy. Acta Neuropathologica. PMID 31686182 DOI: 10.1007/S00401-019-02087-9 |
0.799 |
|
| 2019 |
Gary C, Lam S, Hérard AS, Koch JE, Petit F, Gipchtein P, Sawiak SJ, Caillierez R, Eddarkaoui S, Colin M, Aujard F, Deslys JP, Brouillet E, Buée L, et al. Encephalopathy induced by Alzheimer brain inoculation in a non-human primate. Acta Neuropathologica Communications. 7: 126. PMID 31481130 DOI: 10.1186/S40478-019-0771-X |
0.605 |
|
| 2019 |
Dupr Eacute E, Danis C, Arrial A, Hanoulle X, Homa M, Cantrelle FX, Merzougui H, Colin M, Rain JC, Buee L, Landrieu I. Single domain antibody fragments as new tools for detection of the neuronal tau protein in cells and in mice studies. Acs Chemical Neuroscience. PMID 31380615 DOI: 10.1021/Acschemneuro.9B00217 |
0.66 |
|
| 2019 |
Albert M, Mairet-Coello G, Danis C, Lieger S, Caillierez R, Carrier S, Skrobala E, Landrieu I, Michel A, Schmitt M, Citron M, Downey P, Courade JP, Buée L, Colin M. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody. Brain : a Journal of Neurology. PMID 31038156 DOI: 10.1093/Brain/Awz100 |
0.662 |
|
| 2019 |
Domise M, Sauvé F, Didier S, Caillerez R, Bégard S, Carrier S, Colin M, Marinangeli C, Buée L, Vingtdeux V. Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process. Cell Death & Disease. 10: 221. PMID 30833547 DOI: 10.1038/S41419-019-1464-X |
0.507 |
|
| 2019 |
Buee L, Danis C, Dupre E, Arrial A, Cantrelle F, Rain J, Colin M, Hanoulle X, Landrieu I. Nanobodies (VHHs) for targeting tau in Alzheimer's disease and tauopathies Ibro Reports. 6. DOI: 10.1016/J.Ibror.2019.07.325 |
0.585 |
|
| 2018 |
Dujardin S, Bégard S, Caillierez R, Lachaud C, Carrier S, Lieger S, Gonzalez JA, Deramecourt V, Déglon N, Maurage CA, Frosch MP, Hyman BT, Colin M, Buée L. Different tau species lead to heterogeneous tau pathology propagation and misfolding. Acta Neuropathologica Communications. 6: 132. PMID 30497516 DOI: 10.1186/S40478-018-0637-7 |
0.817 |
|
| 2018 |
Marinangeli C, Didier S, Ahmed T, Caillerez R, Domise M, Laloux C, Bégard S, Carrier S, Colin M, Marchetti P, Ghesquière B, Balschun D, Buée L, Kluza J, Vingtdeux V. AMP-Activated Protein Kinase Is Essential for the Maintenance of Energy Levels during Synaptic Activation. Iscience. 9: 1-13. PMID 30368077 DOI: 10.1016/J.Isci.2018.10.006 |
0.482 |
|
| 2018 |
Susloparova A, Coffinier Y, Alibart F, Thomy V, Arscott S, Pallecchi E, Begard S, Halliez S, Colin M, Buée L. Fabrication of new transparent MEAs made from pure PEDOT:PSS and their optical/electrical properties for neurons' activity assessment in the frame of Alzheimer disease case study Frontiers in Cellular Neuroscience. 12. DOI: 10.3389/Conf.Fncel.2018.38.00035 |
0.507 |
|
| 2018 |
Albert M, Caillierez R, Danis C, Lieger S, Bégard S, Mairet-Coello G, Courade J, Citron M, Buee L, Colin M. O4-05-05: Prevention Of Tau Seeding And Spreading In Transgenic Mouse Models Based On Intracranial-Injection Of P301L-K18 Fibrils Or Alzheimer'S Disease Lysate By Passive Immunotherapy Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2937 |
0.547 |
|
| 2017 |
Mudher A, Colin M, Dujardin S, Medina M, Dewachter I, Naini SMA, Mandelkow EM, Mandelkow E, Buée L, Goedert M, Brion JP. What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathologica Communications. 5: 99. PMID 29258615 DOI: 10.1186/S40478-017-0488-7 |
0.808 |
|
| 2017 |
d'Orange M, Aurégan G, Cheramy D, Gaudin-Guérif M, Lieger S, Guillermier M, Stimmer L, Joséphine C, Hérard AS, Gaillard MC, Petit F, Kiessling MC, Schmitz C, Colin M, Buée L, et al. Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat. Brain : a Journal of Neurology. PMID 29253129 DOI: 10.1093/Brain/Awx342 |
0.688 |
|
| 2017 |
Colin M, Tardivel M, Bégard S, Bousset L, Dujardin S, Richetin K, Deglon N, Melki R, Buee L. Tau Spreading: How Are Tau Assemblies Transferred From Cell To Cell? Alzheimers & Dementia. 13: 906. DOI: 10.1016/J.Jalz.2017.07.320 |
0.763 |
|
| 2016 |
Tardivel M, Bégard S, Bousset L, Dujardin S, Coens A, Melki R, Buée L, Colin M. Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies. Acta Neuropathologica Communications. 4: 117. PMID 27809932 DOI: 10.1186/S40478-016-0386-4 |
0.787 |
|
| 2016 |
Mansuroglu Z, Benhelli-Mokrani H, Marcato V, Sultan A, Violet M, Chauderlier A, Delattre L, Loyens A, Talahari S, Bégard S, Nesslany F, Colin M, Souès S, Lefebvre B, Buée L, et al. Loss of Tau protein affects the structure, transcription and repair of neuronal pericentromeric heterochromatin. Scientific Reports. 6: 33047. PMID 27605042 DOI: 10.1038/Srep33047 |
0.593 |
|
| 2016 |
Buee L, Dujardin S, Tardivel M, Begard S, Caillierez R, Bousset L, Melki R, Colin M. The ins and outs of tau propagation Neurobiology of Aging. 39. DOI: 10.1016/J.Neurobiolaging.2016.01.071 |
0.78 |
|
| 2015 |
Rosseels J, Van den Brande J, Violet M, Jacobs D, Grognet P, Lopez J, Huvent I, Caldara M, Swinnen E, Papegaey A, Caillierez R, Buée-Scherrer V, Engelborghs S, Lippens G, Colin M, et al. Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics. The Journal of Biological Chemistry. 290: 4059-74. PMID 25540200 DOI: 10.1074/Jbc.M114.627919 |
0.652 |
|
| 2015 |
Dujardin S, Colin M, Buée L. Invited review: Animal models of tauopathies and their implications for research/translation into the clinic. Neuropathology and Applied Neurobiology. 41: 59-80. PMID 25428793 DOI: 10.1111/Nan.12200 |
0.77 |
|
| 2015 |
Buee L, Colin M, Dujardin S, Badin RA, Bemelmans A, Jan C, Camp NV, Deglon N, Hantraye P. Non-human primate model of tauopathy Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.060 |
0.676 |
|
| 2014 |
Dujardin S, Bégard S, Caillierez R, Lachaud C, Delattre L, Carrier S, Loyens A, Galas MC, Bousset L, Melki R, Aurégan G, Hantraye P, Brouillet E, Buée L, Colin M. Ectosomes: a new mechanism for non-exosomal secretion of tau protein. Plos One. 9: e100760. PMID 24971751 DOI: 10.1371/Journal.Pone.0100760 |
0.793 |
|
| 2014 |
Dujardin S, Lécolle K, Caillierez R, Bégard S, Zommer N, Lachaud C, Carrier S, Dufour N, Aurégan G, Winderickx J, Hantraye P, Déglon N, Colin M, Buée L. Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies. Acta Neuropathologica Communications. 2: 14. PMID 24479894 DOI: 10.1186/2051-5960-2-14 |
0.8 |
|
| 2014 |
Dujardin S, Brouillet E, Hantraye P, Colin M, Buée L. Which Tau species are toxic? Consequences for therapeutic approaches Neurobiology of Aging. 35: S4. DOI: 10.1016/J.Neurobiolaging.2014.01.042 |
0.74 |
|
| 2013 |
Caillierez R, Bégard S, Lécolle K, Deramecourt V, Zommer N, Dujardin S, Loyens A, Dufour N, Aurégan G, Winderickx J, Hantraye P, Déglon N, Buée L, Colin M. Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1358-68. PMID 23609018 DOI: 10.1038/Mt.2013.66 |
0.806 |
|
| 2013 |
Buee L, Dujardin S, Bégard S, Raphaëlle C, Lécolle K, Dufour N, Auregan G, Winderickx J, Philippe H, Deglon N, Colin M. In vivo tau spreading relies on the transsynaptic transfer of soluble wild-type tau species Alzheimers & Dementia. 9: 142. DOI: 10.1016/J.Jalz.2013.04.090 |
0.772 |
|
| 2012 |
Deramecourt V, Lebert F, Maurage CA, Fernandez-Gomez FJ, Dujardin S, Colin M, Sergeant N, Buée-Scherrer V, Clot F, Ber IL, Brice A, Pasquier F, Buée L. Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S. Journal of Alzheimer's Disease : Jad. 31: 741-9. PMID 22699846 DOI: 10.3233/Jad-2012-120160 |
0.738 |
|
| 2011 |
Sultan A, Nesslany F, Violet M, Bégard S, Loyens A, Talahari S, Mansuroglu Z, Marzin D, Sergeant N, Humez S, Colin M, Bonnefoy E, Buée L, Galas MC. Nuclear tau, a key player in neuronal DNA protection. The Journal of Biological Chemistry. 286: 4566-75. PMID 21131359 DOI: 10.1074/Jbc.M110.199976 |
0.607 |
|
| 2011 |
Lécolle K, Buee L, Colin M, Bégard S, Caillierez R, Zommer N, Blum D, Hantraye P, Deglon N. Lentiviral delivery of human wild-type Tau protein mediates a slow and progressive spatio-temporal Tau pathology in rat brain Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.321 |
0.615 |
|
| 2011 |
Sultan A, Nesslany F, Violet M, Loyens A, Talahari S, Mansuroglu Z, Marzin D, Sergeant N, Humez S, Colin M, Bonnefoy E, Buée L, Galas M. Nuclear tau protects DNA in stress condition Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1416 |
0.46 |
|
| 2011 |
Letronne F, Laumet G, Demiautte F, Colin M, Ayral A, Hot D, Hansmannel F, Mounier A, Berr C, Huot L, Checler F, Pasquier F, Hauw J, Lemoine Y, Buee L, et al. Characterization of a new ADAM as a key player of the APP metabolism Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1125 |
0.422 |
|
| 2010 |
Buée L, Blum D, Bombois S, Buée-Scherrer V, Caillet-Boudin ML, Colin M, Deramecourt V, Dhaenens CM, Galas MC, Hamdane M, Humez S, Maurage CA, Pasquier F, Sablonnière B, Schraen-Maschke S, et al. [Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?]. ThéRapie. 65: 401-7. PMID 21144474 DOI: 10.2515/Therapie/2010054 |
0.403 |
|
| Show low-probability matches. |